CY2052B1 - Polymyxin conjugates - Google Patents

Polymyxin conjugates

Info

Publication number
CY2052B1
CY2052B1 CY9802052A CY9802052A CY2052B1 CY 2052 B1 CY2052 B1 CY 2052B1 CY 9802052 A CY9802052 A CY 9802052A CY 9802052 A CY9802052 A CY 9802052A CY 2052 B1 CY2052 B1 CY 2052B1
Authority
CY
Cyprus
Prior art keywords
polymyxin
conjugates
polymyxin conjugates
bloodstream
potent
Prior art date
Application number
CY9802052A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of CY2052B1 publication Critical patent/CY2052B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
CY9802052A 1989-11-15 1998-04-30 Polymyxin conjugates CY2052B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43748789A 1989-11-15 1989-11-15

Publications (1)

Publication Number Publication Date
CY2052B1 true CY2052B1 (en) 1998-04-30

Family

ID=23736660

Family Applications (1)

Application Number Title Priority Date Filing Date
CY9802052A CY2052B1 (en) 1989-11-15 1998-04-30 Polymyxin conjugates

Country Status (17)

Country Link
EP (1) EP0428486B1 (ko)
JP (1) JPH082917B2 (ko)
KR (1) KR0184858B1 (ko)
AT (1) ATE111746T1 (ko)
AU (1) AU639952B2 (ko)
CA (1) CA2029997A1 (ko)
CY (1) CY2052B1 (ko)
DE (1) DE69012747T2 (ko)
DK (1) DK0428486T3 (ko)
ES (1) ES2063326T3 (ko)
HK (1) HK49696A (ko)
HU (1) HU210901A9 (ko)
IE (1) IE65268B1 (ko)
IL (1) IL96326A (ko)
MY (1) MY104520A (ko)
NZ (1) NZ236050A (ko)
ZA (1) ZA909187B (ko)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545721A (en) * 1992-12-21 1996-08-13 Ophidian Pharmaceuticals, Inc. Conjugates for the prevention and treatment of sepsis
JPH08504824A (ja) * 1992-12-21 1996-05-28 オフィディアン ファーマシューティカルズ，インコーポレーテッド 敗血症の予防および治療
US6660267B1 (en) 1992-12-21 2003-12-09 Promega Corporation Prevention and treatment of sepsis
US6579696B1 (en) * 1992-12-21 2003-06-17 Promega Corporation Polymyxin B conjugates
US6180134B1 (en) 1993-03-23 2001-01-30 Sequus Pharmaceuticals, Inc. Enhanced ciruclation effector composition and method
EP0720485B1 (en) * 1993-09-22 2003-11-19 Henry M. Jackson Foundation For The Advancement Of Military Medicine Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
US5849301A (en) * 1993-09-22 1998-12-15 Henry M. Jackson Foundation For The Advancement Of Military Medicine Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents
JP2581425B2 (ja) * 1993-11-12 1997-02-12 株式会社島津製作所 ペプチド合成用支持体及びそれを用いて製造されたペプチド
DE122009000056I1 (de) * 1995-03-22 2010-01-28 Jackson H M Found Military Med Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden
EP0814833B1 (en) * 1995-03-22 2003-05-28 Henry M. Jackson Foundation For The Advancement Of Military Medicine Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US5691304A (en) * 1995-05-25 1997-11-25 Novartis Ag Improved process for preparing polymyxin B/dextran conjugates
US6309646B1 (en) 1996-05-09 2001-10-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Protein-polysaccharide conjugate vaccines and other immunological reagents prepared using homobifunctional and heterobifunctional vinylsulfones, and processes for preparing the conjugates
US5998381A (en) * 1996-12-06 1999-12-07 Ophidian Pharmaceuticals, Inc. Compounds that bind bacterial pili
IT1312110B1 (it) 1999-05-18 2002-04-04 Istituto Biochimico Pavese Pha Addotti antibiotico-polimero polisaccaridico naturale
DE10129369C1 (de) * 2001-06-21 2003-03-06 Fresenius Kabi De Gmbh Wasserlösliches, einen Aminozucker aufweisendes Antibiotikum in Form eines Pol ysaccharid-Konjugats
AT507846B1 (de) * 2009-01-22 2011-12-15 Fresenius Medical Care De Gmbh Sorptionsmittel für endotoxine
PT3200827T (pt) * 2014-10-03 2020-10-08 Xellia Pharmaceuticals Aps Composições
CN109843315A (zh) * 2016-10-21 2019-06-04 阿尔吉法玛公司 多粘菌素-藻酸盐低聚物缀合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7702261L (sv) * 1976-03-02 1977-09-07 Pharmaco Inc Forfarande for att immobilisera antimikrobiella emnen
JPS5813519A (ja) * 1981-07-16 1983-01-26 Seikagaku Kogyo Co Ltd エンドトキシン吸着材及びそれを用いるエンドトキシンの除去方法
US4496689A (en) * 1983-12-27 1985-01-29 Miles Laboratories, Inc. Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer

Also Published As

Publication number Publication date
CA2029997A1 (en) 1991-05-16
IL96326A0 (en) 1991-08-16
AU6655590A (en) 1991-05-23
EP0428486A1 (en) 1991-05-22
JPH082917B2 (ja) 1996-01-17
AU639952B2 (en) 1993-08-12
NZ236050A (en) 1993-04-28
KR0184858B1 (ko) 1999-05-01
ATE111746T1 (de) 1994-10-15
EP0428486B1 (en) 1994-09-21
ES2063326T3 (es) 1995-01-01
IE904105A1 (en) 1991-05-22
MY104520A (en) 1994-04-30
HU210901A9 (en) 1995-09-28
DK0428486T3 (da) 1995-01-09
KR910009274A (ko) 1991-06-28
IL96326A (en) 1995-07-31
IE65268B1 (en) 1995-10-18
JPH03220198A (ja) 1991-09-27
DE69012747D1 (de) 1994-10-27
ZA909187B (en) 1992-07-29
HK49696A (en) 1996-03-29
DE69012747T2 (de) 1995-03-16

Similar Documents

Publication Publication Date Title
ZA909187B (en) Polymyxin conjugates
EP0537299A4 (en) DISULFIDE CONJUGATES OF OLIGONUCLEOTIDE TRANSPORT AGENTS.
AU6290090A (en) Bi-or trispecific (fab)3 or (fab)4 conjugates
DK0555361T3 (da) Pulverformige farvepræparater og fremgangsmåde til fremstilling deraf
AU9050291A (en) Tacking agent
HU911672D0 (en) Tfg-beta preparations
HU911678D0 (en) N-phosphonomethylglycine based herbicide preparations
AU4451389A (en) Antibody-drug conjugates
DE68905241D1 (en) Tracheobronchodilatator.
AU4066089A (en) Novel tc-99m complexes
GB9001694D0 (en) Immunogenic compositions
GB9105811D0 (en) Lipopeptide derivatives
ZA911978B (en) Lipopeptide derivatives
AU8876591A (en) Indole-3-methanamines useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
EP0484403A4 (en) Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines
EP0504136A4 (en) Tolerogenic immunoglobulin-protein conjugates
ZA918381B (en) Pharmaceutical compositions.
GB9013779D0 (en) Self-lubricating,two stage variable compressor
AU8438291A (en) Algaas native oxide
GB9115345D0 (en) Lipopeptide derivatives
AU7249491A (en) Improved immunogenic compositions
GB9021393D0 (en) Peroxide compositions
AU5090290A (en) Tolerogenic immunoglobulin-protein conjugates
NZ240927A (en) Dibenz-oxa-thiocinones; preparatory processes, uses, and pharmaceutical compositions
IE901924L (en) 1,2-dioxetanes.